Lucy Brady
Known title: DirectorCIK: 0001965642
Lucy Brady's purchase track record
Lucy Brady has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/21/2025 | BBWI | $50K | +65.5% | +20.6% | +13.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BBWI | ▲ Buy | Grant | 7,970 | $0 | 6/11/2026 | View on chart |
| BBWI | ▲ Buy | Open Market | 3,470 | $50K | 11/21/2025 | View on chart |
| BBWI | ▲ Buy | Grant | 5,641 | $0 | 6/5/2025 | View on chart |
| BBWI | ▲ Buy | Grant | 3,844 | $0 | 6/27/2024 | View on chart |
| BBWI | ▲ Buy | Grant | 3,572 | $0 | 6/8/2023 | View on chart |
| BBWI | ▲ Buy | Grant | 955 | $0 | 3/9/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
BBWI shares jump 8.7% amid product innovation news
Bath & Body Works stock rose 8.7% recently, a move linked to its push into sensitive-skin products and broader product innovation. This strategy aims to support pricing as consumers look for value. The company also has a low P/E ratio of 4.5, which some analysts view as undervalued, though questions remain about its long-term outlook.
BBWI shares jump 8.7% amid product innovation news. Bath & Body Works stock rose 8.7% recently, a move linked to its push into sensitive-skin products and broader product innovation. This strategy aims to support pricing as consumers look for value. The company also has a low P/E ratio of 4.5, which some analysts view as undervalued, though questions remain about its long-term outlook.